Cessation versus continuation of 6-month migraine preventive therapy with topiramate (PROMPT): a randomised, double-blind, placebo-controlled trial
Year: 2007
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: The Lancet Neurology
Institutions: University of Duisburg-Essen, Janssen (Germany), Fondazione IRCCS Istituto Neurologico Carlo Besta, Royal Stoke University Hospital, Istanbul University, Centre Hospitalier Universitaire de Nice, Hôpital Pasteur, Charité – Universitätsmedizin Berlin, Hospital Ruber Internacional, University of Liège
Language: English
Subfield: Clinical Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2106884116
